Ersoy Kocabicak
Overview
Explore the profile of Ersoy Kocabicak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhang J, Tsui K, Lee H, Aquili L, Wong K, Kocabicak E, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796199
Melatonin is a hormone released by the pineal gland that regulates the sleep-wake cycle. It has been widely studied for its therapeutic effects on Alzheimer's disease (AD), particularly through the...
2.
Eser P, Kocabicak E, Bekar A, Temel Y
Exp Neurol
. 2024 Jan;
374:114684.
PMID: 38199508
Parkinson's disease, a progressive neurodegenerative disorder, involves gradual degeneration of the nigrostriatal dopaminergic pathway, leading to neuronal loss within the substantia nigra pars compacta and dopamine depletion. Molecular factors, including...
3.
Eser P, Kocabicak E, Bekar A, Temel Y
Exp Neurol
. 2023 Dec;
372:114644.
PMID: 38061555
Parkinson's disease, a progressive neurodegenerative disorder predominantly affecting elderly, is marked by the gradual degeneration of the nigrostriatal dopaminergic pathway, culminating in neuronal loss within the substantia nigra pars compacta...
4.
Yasar O, Ozturk S, Kemal O, Kocabicak E
Turk Neurosurg
. 2022 Apr;
32(5):764-772.
PMID: 35416268
Aim: To investigate the effects of deep brain stimulation (DBS) of the subthalamic nucleus (STN) on acoustic characteristics of voice production in Turkish patients with Parkinson's disease (PD). Material And...
5.
Taskin O, Kocabicak E, Ozturk S, Yildiz O, Temel Y
Turk Neurosurg
. 2022 Feb;
32(3):449-458.
PMID: 35147967
Aim: To examine the postoperative outcomes of electrode fixation using bone cement and Stimloc® in patients with Parkinson?s disease (PD) who underwent subthalamic nucleus (STN) deep brain stimulation (DBS). Material...
6.
Nassehi B, Assadnejad T, Yildiz O, Aygun D, Kocabicak E
Turk Neurosurg
. 2022 Feb;
32(3):513-516.
PMID: 35147965
Aim: Deep brain stimulation (DBS) is a well-established treatment option for improving function and quality of life (QoL) in carefully selected patients with Parkinson?s disease (PD). Patient selection is a...
7.
Nassehi B, Kocabicak E, Temel Y, Hescham S
Turk Neurosurg
. 2022 Feb;
32(4):535-548.
PMID: 35147964
Alzheimer's disease (AD) is the most common type of dementia that causes disabilities in memory formation and activities of daily living. Unfortunately, pharmacologic treatments have minimal and short-lasting effects on...
8.
Habets J, Herff C, Fasano A, Beudel M, Kocabicak E, Schnitzler A, et al.
Stereotact Funct Neurosurg
. 2021 Nov;
100(2):121-129.
PMID: 34823246
Background: Subthalamic nucleus deep brain stimulation (STN DBS) is an established therapy for Parkinson's disease (PD) patients suffering from motor response fluctuations despite optimal medical treatment, or severe dopaminergic side...
9.
Ozturk S, Temel Y, Aygun D, Kocabicak E
World Neurosurg
. 2021 Jul;
154:e495-e508.
PMID: 34303854
Objective: Deep brain stimulation (DBS) is a frequently applied therapy in primary dystonia. For secondary dystonia, the effects can be less favorable. We share our long-term findings in 9 patients...
10.
Kocabicak E, Yildiz O, Aygun D, Temel Y
Turk Neurosurg
. 2020 Nov;
31(1):88-92.
PMID: 33216337
Aim: To investigate the effect of preoperative levodopa responsiveness to clinical outcomes in the first postoperative year, and to evaluate the changes in the postoperative levodopa responsiveness in patients undergoing...